Free shipping

Pomegranate for Hot Flashes: Seed Oil, Symptom Scores and Follow-Up

The seed-oil trial's twelve-week result differed from its later visit. A second study measured broader menopause symptoms.

Woman reading a closed supplement carton beside a plain amber bottle, blank symptom diary and whole pomegranate.
In this article
  1. The seed-oil trial: keep the placebo result beside the percentage
  2. A different study measured overall symptom scores
  3. A positive review still needs its limitations
  4. What to discuss before buying

A pomegranate supplement is not one standardized menopause treatment. Seed oil and other extracts need their own evidence. NCCIH1 notes that many human pomegranate studies used juice rather than supplements, and that limited research does not support conclusions for most proposed health uses.1

The seed-oil trial: keep the placebo result beside the percentage

The 2012 randomized, double-blind trial2 was completed by 81 postmenopausal women. It tested 30 mg pomegranate seed oil twice daily for twelve weeks against placebo.2

Hot-flash frequency fell 38.7% with seed oil and 25.6% with placebo. Both groups improved from baseline, but the between-group comparison was not statistically significant (P=0.17). Quoting only the 38.7% decline would omit the comparison needed to judge the supplement.2

At week 24, the original abstract reported 7.1 hot flashes daily in the seed-oil group versus 8.8 with placebo (P=0.02). That later finding deserves investigation; it does not turn the twelve-week comparison into a positive one or establish a dependable long-term effect from this small trial.2

A different study measured overall symptom scores

The 2022 double-blind trial3 involved 78 healthy women and reported benefit after four weeks of a pomegranate supplement. Its measures were the modified-Kupperman index and Menopause-Specific Quality of Life questionnaire (MENQOL), with reported between-group differences of P<0.001.3

Those are broader questionnaires, not simply daily hot-flash counts. The original abstract does not supply a numerical hot-flash-frequency effect or enough formulation detail to match a shop product. It also describes follow-up as three weeks without intervention in the methods and four weeks in the conclusion. That reporting inconsistency limits a precise claim about persistence after stopping.3

These trials therefore cannot be treated as repeat tests of an identical product and outcome. A symptom-score improvement can be useful while still leaving the daily number of flashes, their severity and their effect on sleep to be examined separately.

A positive review still needs its limitations

The 2023 pomegranate review reported possible symptom benefits, but its eligibility extended beyond randomized trials to before-and-after studies, case reports and case series. Its authors described much of the evidence as inconclusive and identified small samples and problems with blinding and randomization.4

A pooled conclusion does not establish that an oil capsule, a juice-based preparation and a different extract will perform alike. Nor does short symptom follow-up establish years of safety or protection against other menopause-related health problems.

There is also a newer nano-emulsified seed-oil study, NCT06432816. As checked on October 15, 2026, the registry had no posted results, a May 2024 last update and an unknown current status. Its estimated July 2026 completion date is not evidence that treatment worked or that the trial finished.5

What to discuss before buying

The US Menopause Society’s 2023 statement does not recommend supplements or herbal remedies for hot flashes. It identifies better-supported nonhormone approaches, including cognitive-behavioral therapy, clinical hypnosis and selected prescription medicines.6 Our nonhormonal hot-flash treatment guide introduces that discussion.

NCCIH1 reports possible digestive symptoms and allergic reactions with pomegranate. It advises discussing herbal products with a health professional when you take medicines. In the US, supplements do not undergo FDA approval before sale; a capsule’s availability does not establish menopause efficacy.1

Chapter 5’s “The Supplement Shelf” in My Body Changed. Now What? connects preparation differences with the placebo problem. Bring the exact product label, the symptom you want to change and your current medicines to an appointment. If you have counted flashes for a week, keep that count beside sleep disruption and bothersomeness, rather than combining all three into “better.”

This article examines selected pomegranate symptom trials and their reporting limits. It does not recommend a supplement or replace a menopause treatment discussion.

Read our health disclaimer

Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.

Sources

The research behind this article, in the order it’s cited. How we source our articles.

  1. NCCIH, 2025Pomegranate: Usefulness and Safety (opens in a new tab)abcd
  2. Auerbach et al., Menopause, 2012Pomegranate seed oil in women with menopausal symptoms: a prospective randomized, placebo-controlled, double-blinded trial (opens in a new tab)abcd
  3. Adel-Mehraban et al., Complementary Therapies in Clinical Practice, 2022Effects of pomegranate supplement on menopausal symptoms and quality of life in menopausal women: A double-blind randomized placebo-controlled trial (opens in a new tab)abc
  4. Moeini et al., Phytotherapy Research, 2023Pomegranate effects on the health aspects of women during peri- and postmenopause: A systematic review and meta-analysis (opens in a new tab)↩
  5. ClinicalTrials.govEfficacy of Nano-Pso Therapy in Menopause (NCT06432816) (opens in a new tab)↩
  6. The Menopause Society, 2023The 2023 nonhormone therapy position statement of The North American Menopause Society (opens in a new tab)↩

Spotted something out of date? Tell us and we’ll check it.

Private questions deserve good answers.

Ten Playbooks, one for each of the problems women rarely talk about.

Shop the Playbooks